 Exclusive contents: images and/or videos
In-stent restenosis (ISR) is usually detectable in bare metal stents 6 to 9 months after deployment, and this time course correlates in most cases with the peak of neointimal hyperplasia, making this time period the one traditionally used as an arbitrary point for assessment of DES restenosis. The development of late ISR remains an unresolved issue. Several reports exist demonstrating severe late ISR in DES who had undergone a reassuring follow-up angiogram post intervention.
We describe one patient who presented with late ISR and crescendo angina pectoris over a 3 week period 36 months after sirolimus stent implantation to his LAD. The ISR was successfully treated with atherectomy and balloon angioplasty.
We believe this is the first report to demonstrate ISR in a DES at such a time point.
click here to reroll the summary
Editorial
48
Editorial
EuroInterv.2006;2:273-275
51
You ain't seen nothing yet...
EuroInterv.2006;2:282-283
EAPCI column
Clinical research
53
A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial
Serruys P.W., Ruygrok P., Neuzner J., Piek J., Seth A., Schofer J., Richardt G., Wiemer M., Carrié D., Thuesen L., Boone E., Miquel-Herbert K., Daemen J.
EuroInterv.2006;2:286-294
54
The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesions
Costa R.A., Eduardo Sousa J., Abizaid A., Chaves A., Feres F., Sousa A., Musumeci G., Mehran R., Fitzgerald P., Lansky A.J., Leon M.B., Shiran A., Halon D., Lewis B., Guagliumi G.
EuroInterv.2006;2:295-301
56
Biodegradable-Polymer-Based, Paclitaxel-Eluting Infinnium™ Stent: 9-Month clinical and angiographic follow-up results from the SIMPLE II prospective multi-centre registry study
Vranckx P., Serruys P.W., Gambhir S., Eduardo Sousa J., Abizaid A., Lemos P., Ribeiro E., Dani S.I., Dalal J.J., Mehan V., Dhar A., Dutta A.L., Reddy K.N., Chand R., Ray A., Symons J., for the SIMPLE II study team
EuroInterv.2006;2:310-317
58
Percutaneous Patent Foramen Ovale (PFO) closure in young patients with both cryptogenic brain infarction and PFO associated with Atrial Septal Aneurysm (ASA)
Juliard J.-M., Abboud H., Aubry P., Brochet E., Sauguet A., Depoix J.P., Philip Y., Messika-Zeitoun D., Lung B., Vahanian A., Amarenco P.
EuroInterv.2006;2:326-329
60
Virtual histology and remodelling index allow in vivo identification of allegedly high-risk coronary plaques in patients with acute coronary syndromes: a three vessel intravascular ultrasound radiofrequency data analysis
García-García H., Goedhart D., Schuurbiers J.C.H., Kukreja N., Tanimoto S., Daemen J., Morel M.-A., Bressers M., van Es G.A., Wentzel J., Gijsen F., van der Steen A., Serruys P.W.
EuroInterv.2006;2:338-344
Expert review
64
Coronary perforations
EuroInterv.2006;2:363-370
How and why
New device
Technical report
20 years of stenting: a patient's perspective
Image in cardiology
Issue 7 has been released thanks to the support of the following partners:
- Cordis, a Johnson & Johnson company
- Boston Scientific
- Medtronic
- Abbott Vascular Devices
- Terumo
- Hexacath
|